All Stories

  1. Multiple Drug Intolerance Syndrome: An Underreported Distinct Clinical Entity

    Article • Current Clinical Pharmacology, October 2019, Bentham Science Publishers

    Sapan Behera, Dr Alphienes Stanley Xavier, Sandhiya Selvarajan

  2. Effect of Cholecalciferol Supplementation on Treatment Response and IL-10 Level in Vitamin D Deficient Parthenium Dermatitis Patients: A Randomized Double-Blind Placebo-Controlled Trial

    Article • Journal of Dietary Supplements, May 2019, Taylor & Francis

    Dr Alphienes Stanley Xavier, Dr laxmisha chandrashekar, Sandhiya Selvarajan

  3. Drug Reaction with Eosinophilia and Systemic Symptoms syndrome

    Article • Hospital Practice, March 2018, Taylor & Francis

    Dr. Saibal Das, Dr Alphienes Stanley Xavier, Sapan Behera, Sandhiya Selvarajan

  4. Acenocoumarol as an alternative anticoagulant in a patient with warfarin-related nephropathy

    Article • British Journal of Clinical Pharmacology, February 2018, Wiley

    Dr Alphienes Stanley Xavier, Satish H

  5. CYP2C19 activity in patients on antituberculosis treatment

    Article • Fundamental and Clinical Pharmacology, July 2016, Wiley

    Dr Alphienes Stanley Xavier

  6. Delamanid: A new armor in combating drug-resistant tuberculosis

    Article • Journal of Pharmacology and Pharmacotherapeutics, January 2014, Medknow

    Dr Alphienes Stanley Xavier

  7. Bedaquiline – The first ATP synthase inhibitor against multi drug resistant tuberculosis

    Article • Journal of Young Pharmacists, December 2013, EManuscript Services

    Dr Alphienes Stanley Xavier